Medical Devices APAC

APAC Cuffless Blood Pressure Monitors Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Cuffless Blood Pressure Monitors Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $83.7 Mn Placeholder estimate
Estimate 2025 $101.5 Mn 23.5% of the global market
Projected 2034 $572.8 Mn 464.3% Adds $471.3 Mn over 9 forecast years
CAGR 2025–2034 21.2% Faster than 94% of 180 Medical Devices markets here
Key players 5
  • APAC is 23.5% of the global market.
  • Among regions, the largest is North America at $220.4 Mn.
  • Fastest growing: APAC (this report) at 21.2% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$471.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Cuffless Blood Pressure Monitors Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $83.7 Mn — —
2025 (base) $101.5 Mn +$17.8 Mn —
2026 (forecast) $123.0 Mn +$21.5 Mn +21.2%
2027 (forecast) $149.1 Mn +$26.1 Mn +46.9%
2028 (forecast) $180.7 Mn +$31.6 Mn +78%
2029 (forecast) $219.0 Mn +$38.3 Mn +115.8%
2030 (forecast) $265.5 Mn +$46.4 Mn +161.5%
2031 (forecast) $321.7 Mn +$56.3 Mn +217%
2032 (forecast) $389.9 Mn +$68.2 Mn +284.2%
2033 (forecast) $472.6 Mn +$82.7 Mn +365.6%
2034 (forecast) $572.8 Mn +$100.2 Mn +464.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Cuffless Blood Pressure Monitors Market Analysis at a glance
Market size, 2025$101.5 Mn placeholder estimate
Forecast, 2034$572.8 Mn placeholder estimate
Growth (CAGR), 2025–203421.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, use and end user (see all)
Key playersAktiia, Omron Healthcare, Samsung Health, Biobeat, Withings (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Cuffless Blood Pressure Monitors Market Analysis Executive Summary

Cuffless blood pressure monitors estimate blood pressure from a watch, ring or patch without an inflatable cuff.

Key segments of the cuffless Blood Pressure Monitors market include product (Wrist Wearables, Patches and Smartphone-Based) and use (Consumer and Clinical).

Bar chart: Asia Pacific Cuffless Blood Pressure Monitors market size, 2024–2034, placeholder estimates. $83.7 Mn in 2024, $101.5 Mn in 2025 and $572.8 Mn in 2034, 21.2% CAGR.
Asia Pacific Cuffless Blood Pressure Monitors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Cuffless Blood Pressure Monitors Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the cuffless Blood Pressure Monitors market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the cuffless Blood Pressure Monitors market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the cuffless Blood Pressure Monitors market.

Competitive Landscape for Cuffless Blood Pressure Monitors Market in APAC

The cuffless Blood Pressure Monitors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Cuffless Blood Pressure Monitors Market in APAC

Cuffless Blood Pressure Monitors in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], Ministry of Health (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Ministry of Health (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cuffless Blood Pressure Monitors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Cuffless Blood Pressure Monitors right now, from free public sources.

Patients

High blood pressure (ages 30–79), % of adults 30–79 (WHO)
CountryValueYear
Afghanistan40.22019
Australia29.32019
Bangladesh28.82019
China27.32019
India31.12019
Indonesia40.32019
Japan31.42019
Malaysia40.82019
Myanmar37.82019
Nepal36.12019
New Zealand30.92019
Pakistan43.22019
Philippines33.82019
Singapore31.52019
South Korea26.72019
Thailand29.22019
Vietnam29.72019
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Cuffless Blood Pressure Monitors in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Cuffless Blood Pressure Monitors market in Asia Pacific?
Placeholder estimate: about $101.5 Mn in 2025, rising to about $572.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cuffless Blood Pressure Monitors market in Asia Pacific growing?
Placeholder estimate: about 21.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cuffless Blood Pressure Monitors market report cover?
The report splits the market by product (Wrist Wearables, Patches, Smartphone-Based), use (Consumer, Clinical) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Cuffless Blood Pressure Monitors market?
Key players include Aktiia, Omron Healthcare, Samsung Health, Biobeat and Withings.
What is driving the Cuffless Blood Pressure Monitors market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the cuffless Blood Pressure Monitors market. Doctors are starting to use wearable data in care decisions.
How much research is published on Cuffless Blood Pressure Monitors?
PubMed lists 220 papers on Cuffless Blood Pressure Monitors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on hypertension and remote monitoring and wearables

See the topic